ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Merck KGaA (PK)

Merck KGaA (PK) (MKKGY)

33.02
-0.55
(-1.64%)
Closed July 16 4:00PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
33.02
Bid
32.62
Ask
33.79
Volume
27,409
33.015 Day's Range 33.305
0.00 52 Week Range 0.00
Previous Close
33.57
Open
33.232
Last Trade
12
@
33.02
Last Trade Time
Average Volume (3m)
-
Financial Volume
$ 908,994
VWAP
33.1641

MKKGY Latest News

Trending: Merck's Multiple Sclerosis Drug Misses Expectations in Late-Stage Trials

1250 GMT - Merck is among the most mentioned companies across news items over the past 12 hours, according to Factiva data, after the German pharmaceutical-and-chemical group said its multiple...

Merck Shares Slump After Multiple Sclerosis Drug Fails in Late-Stage Trials

By Helena Smolak Shares of Germany's Merck KGaA plunged after its experimental drug evobrutinib failed in two late-stage trials of patients with relapsing forms of multiple sclerosis. At 0927...

Merck MS Drug Fails to Meet Target of Late-Stage Trials

By David Sachs Merck's multiple sclerosis drug evobrutinib didn't meet a key goal in late-stage trials. The German pharmaceutical company's phase 3 clinical trials for the drug did...

Merck to Pay at Least $70 Million for Rights to Abbisko Joint-Tumor Drug

By David Sachs Merck has a deal worth at least $70 million with Abbisko Therapeutics to commercialize a drug to treat joint tumors. The German pharmaceutical company said Monday that its deal with...

Merck KGaA Sees Earnings, Sales at Lower Half of Outlook Ranges

By Adria Calatayud Germany's Merck KGaA expects earnings and sales for 2023 to be at the lower half of its outlook ranges, after reporting lower third-quarter revenue across all segments. The...

Merck KGaA Weighs Job Cuts at Electronics Division on Market Downturn

By Helena Smolak Germany's Merck KGaA is contemplating job cuts within its electronics division as part of a cost-saving initiative prompted by a market downturn that is lasting longer than...

Merck KGaA Enters Partnership With China's Hengrui for Up to $1.5 Billion

By Adria Calatayud Germany's Merck KGaA has entered into a partnership to license a cancer drug developed by China's Jiangsu Hengrui Pharmaceuticals for up to 1.4 billion euros ($1.48...

Merck KGaA Shares Jump on Expected Return to Sales Growth in 2024

By Adria Calatayud Shares of Germany's Merck KGaA rose after the company forecast a return to organic sales growth next year, supported by recovering demand for semiconductor materials and...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AMIXAutonomix Medical Inc
$ 1.3701
(121.70%)
154.81M
SHOTWSafety Shot Inc
$ 0.41
(115.79%)
7.56k
DATSDatChat Inc
$ 1.89
(81.73%)
54.75M
CYNCYNGN Inc
$ 9.18
(53.77%)
17.79M
SCNIScinai Immunotherapeutics Ltd
$ 5.80
(42.86%)
29.37M
ASLNASLAN Pharmaceuticals Ltd
$ 1.36
(-46.67%)
1.16M
KZIAKazia Therapeutics Ltd
$ 0.5593
(-37.56%)
15.34M
LCFYLocafy Ltd
$ 3.5597
(-36.32%)
584.38k
NAASNaaS Technology Inc
$ 2.82
(-33.02%)
1.94M
ZENVZenvia Inc
$ 1.67
(-26.75%)
658.26k
FFIEFaraday Future Intelligent Electric Inc
$ 0.5152
(22.09%)
217.92M
NVDANVIDIA Corporation
$ 128.44
(-0.62%)
208.32M
SQQQProShares UltraPro Short QQQ
$ 7.46
(-0.67%)
155.14M
AMIXAutonomix Medical Inc
$ 1.3701
(121.70%)
154.81M
TSLATesla Inc
$ 252.64
(1.78%)
147.31M

Discussion

View Full Feed
PickStocks PickStocks 3 minutes ago
Yes…and he also said real soon months ago
COOP
Fdc4 Fdc4 12 minutes ago
I guess you are about to have some proof of your own by now. Ouch… Averaging down now, right? Buying the cheapies
IGPK
GVInvestments GVInvestments 14 minutes ago
I'm holding till $300.00 per share.
FNMA
HippyTrades HippyTrades 14 minutes ago
Your head is literally spinning because you know that was a horrible annual report and you can't face it
AXXA
vinmantoo vinmantoo 17 minutes ago
No data on clinical endpoints.

Thanks for the link. Pretty telling that they didn't include symptom relief data.
HippyTrades HippyTrades 17 minutes ago
The buyback fund?
Wow do you ever make stuff up.
What do you think a disclosure is?
AXXA
DocLee DocLee 19 minutes ago
In "Nature", (12th July) another effective treatment (Car-T) for brain tumours (this time in children) which might complement DCVax (and would be less toxic). The article is at https://www.nature.com/articles/d41586-024-02255-2?utm_source=Live+Audience&utm_campaign=f8586bf0ce-nature-briefing-daily
NWBO
Wise Man Wise Man 24 minutes ago
Error in the hyperlink to the CFR 1229.13 posted before, that inserted a new capital distribution: the Lamberth rebate (Number 3), thanks to an express grant of authority of FHFA in the law to do it (Number 3 in the FHEFSSA definition of capital distribution, posted before).
Chevron deference
FNMA
nowwhat2 nowwhat2 27 minutes ago
1 HR LATER.......


https://investorshub.advfn.com/uimage/uploads/2024/7/16/qtmkceth_777_15_5d_945pm_chan_3500_Gee.jpg

1 HR LATER.......WHUMP !
https://investorshub.advfn.com/uimage/uploads/2024/7/16/facjveth_777_15_5d_1045pm_chan_3500_WHUMP.jpg
BTCUSD
nowwhat2 nowwhat2 27 minutes ago
1 HR LATER.......


https://investorshub.advfn.com/uimage/uploads/2024/7/16/qtmkceth_777_15_5d_945pm_chan_3500_Gee.jpg

1 HR LATER.......WHUMP !
https://investorshub.advfn.com/uimage/uploads/2024/7/16/facjveth_777_15_5d_1045pm_chan_3500_WHUMP.jpg
ETHUSD
Sltan Sltan 29 minutes ago
100X
RNVA
Sltan Sltan 30 minutes ago
I hope we see
0.01
Earnings results
Fusion
to divide
Million profits
Price 0.0001
Chance of achieving x100
🤑🤑🤑🤑🤑🤑
RNVA
sentiment_stocks sentiment_stocks 36 minutes ago
And if your feeling particularly brave, why not contact the Chair of the CHM ?..

p.mulholland@ucl.ac.uk

You know that it was Paul Mullholland who presented the DCVax-L P3 data results at New York Academy of Sciences in about an hour long presentation on May 20, 2023, ri
NWBO
cootcat cootcat 37 minutes ago
60f1 you just show up to let us know this is a scam. ARE you new or just a different name? But you are not the first to make that statement or that claim. One has to remember that this is micro penny stock. How many micro pennies stock are call scams and actual are?
ILUS
rikkie rikkie 41 minutes ago
Calimero !
LWLG
BugStrong BugStrong 44 minutes ago
Today we shall see how the flow is.
WDLF
LazyInvestor LazyInvestor 46 minutes ago
What do you mean? The only financial records they needed to be current were for the 10Q for Q1 which were due in May. Or am I missing something here?
BEGI
BugStrong BugStrong 49 minutes ago
I thought more info on the companies in the incubator would have been talked, more details.
WDLF
Louinjaxxx Louinjaxxx 50 minutes ago
Maybe you don't want the company to audit the lndustries the company is involved in because it could make the company a great find in OTCMarkets.

Maybe you don't like how the CEO is managing the company because you think you could do better (CEO- envy).
AXXA
Wise Man Wise Man 51 minutes ago
Summary of the current state of Fanniegate: Chevron deference🆚Rogues.

Justice Alito can't make laws. What he was doing with his opinion, was to endorse the Separate Account plan, whether he likes it or not. His spin isn't even taken into consideration: "Rehabilitate FnF in a w
FNMA
Twister Twister 52 minutes ago
Military AR perhaps brighter than events/delays have appeared!

Delayed acceptance, budgets and depth of product scope remain attractive.
Corporate belt tightening is very real and military training budget cuts likely to continue.

Seeing continued interest by othe
VTSI
Fdc4 Fdc4 55 minutes ago
I wouldn’t be surprised if it is higher. JFHE posted Q2 coming and strong. So, it shall be higher at least. What I don’t understand is why name change is taking too long
IGPK
Louinjaxxx Louinjaxxx 56 minutes ago
It depends...which do you prefer, 62 mil debt or 31 mil debt?
AXXA
conix conix 57 minutes ago
Things are really looking up for Biden to roll over Trump in November.

Stay Positive. Biden did GREAT in that Lester Holt interview this evening. Sharp as a tack.

spdpro spdpro 59 minutes ago
D > interesting
In the "past" with StreetSmartPro you could do that with advanced brackets >

I'm looking at TOS Web now and do not see any way to do things outside
of 2 differing order trades on 2 trade tickets to accomplish your 1 goal >
Even with >>> And Or